Animal Probiotics Market Report

Animal probiotics are specific strains of microorganisms that are fed to animals in the proper amount to have a positive impact. The use of probiotics as feed additives in animal production has increased significantly over the last decade, particularly since the livestock sector banned the use of antibiotic growth promoters. Additionally, growing awareness of the benefits of animal probiotics among poultry and cattle farmers, as well as pet owners, creates new opportunities for animal probiotic manufacturers. Probiotics are also considered to be a safe and efficient alternative to antibiotics. According to the Natural Resources Defence Council, antibiotic resistance causes more than 2.8 million infections and between 35,000 and 162,000 animal deaths in the United States each year. To effectively manage antibiotic resistance, other control and management strategies are required. The growing demand for alternative control and management strategies to combat antibiotic-resistant diseases in animals drives the market for probiotics.  Additionally, the European and U.S. bans on the use of antibiotics has created a significant demand for natural growth promoters. Protecting public health and generating long-term value are the primary goals of the Farm Animal Investment Risk and Return Initiative (FAIRR). This initiative has convinced 20 global food firms to limit antibiotic use in global supply chains. This can be achieved by adopting an antibiotics policy to phase out routine, prophylactic usage across all supply chains, specifying clear implementation objectives and timelines, and increasing transparency by reporting on implementation and data verification.

High costs of procuring qualified professionals, expenditures on R&D activities and on laboratories and research equipment are some of the factors that hinder the market development for animal probiotics. The effectiveness of using probiotics in different areas has been approved scientifically; therefore, it can be considered to be a successful market. Since the production of probiotics has health advantages, the firm has difficulty in recovering its initial investment. For instance, in August 2023, Ozona Organics conducted a recall of some liquid probiotic products because of a possible health hazard resulting from high water activity in the formula that results in microbial development. In addition, in 2024, a new product known as Similac Probiotic Tri-Blend contains B. infantis (Bb-02), S. thermophilus (TH-4), and B. lactis (BB-12). This item is not meant for use in infants and its recall is not related to issues that the agency is having with Abbott Nutrition particularly the powdered infant formula. It has pulled its Similac Probiotic Tri-Blend product off the shelves and is working with the FDA to put these additional fixes into effect.

Companies in the animal probiotics sector are working together to enhance their research and development efforts. These collaborations allow for the fusion of expertise and resources to develop advanced probiotic formulas and innovative delivery techniques. In June 2023, Floré by Sun Genomics, the only precision probiotic customized to individual needs, revealed a partnership with DSM Ventures, a health, nutrition, and bioscience investment company. In February 2023, Evonik enhanced and expanded probiotics manufacturing at its facility in León, Spain, setting the stage for future development in the Gut Health Solutions sector. The production capacity of Ecobiol, Fecinor, and GutCare has increased by more than two times. Furthermore, in July 2022, the U.K. bacteria manufacturing facility of Lallemand Animal Nutrition was expanded to keep up with the increasing market need for live bacteria in probiotics and silage inoculant products. The new facility effectively doubles packaging capacity and boosts fermentation capacity by 150%.

China and India are major revenue generators in the Asia-Pacific region. These countries have contributed a large population base, as well as a rise in the number of middle-class people who prefer food with health advantages as they adapt to an urbanized lifestyle. According to The Poultry Federation, China's poultry probiotics industry is projected to generate revenue over US$ 250 million by 2024, owing to rising broiler meat consumption and per-capita disposable income. This has raised demand for poultry products in the region, which has fuelled the expansion of probiotics in the region.  Europe is anticipated to have the second-largest share of the global animal probiotics market during the forecast period due to a ban on the use of antibiotics that promote animal growth, which has increased demand for animal probiotics.